All News

Four terpenes were tested for their effects in management of post-operative and fibromyalgia pain.

GVB Biopharma announced their new CBT Isolate product.

Here, we bring you our top five recent news articles covering International Women's Day, cannabis research and surveys, and regulation updates.

The two surveys gathered information on cannabis and driving perceptions as well as effective safety messages for drivers.

California extends ban on hemp products containing any amount of THC.

The partnership is intended to support the infrastructure, compliance, and innovation in the industry.

Ispire Technology recently announced in a press release their new all-in-one vape product called Sprout.

Nearly 20,000 US adults were asked about the harm of regular cannabis use and regular alcohol use.

A recent study sought to look into improving sleep quality through the use of hemp-derived cannabinoids.

In this roundup article, we are excited to share with you our roundup of interviews from our December 2024 Women in Analytical Science Supplement.

Here, we bring you our top five recent news articles covering our latest publication, workplace safety for cannabis businesses, the latest cannabis research, and more.

In this roundup article, we are excited to share with you our roundup of interviews with female leaders in the industry.

The new initiative is meant to help advance women and allied businesses in cannabis and hemp.

Check out our exciting 2025 International Women's Day coverage!

In honor of International Women’s Day on March 8, 2025, we are excited to share with you our themed round up of women’s research.

The Commission provided information on testing updates intended to increase product safety and transparency.

Researchers analyzed data from more than 1000 young adults, linking heavy lifetime and recent use to diminished brain activation in some areas.

ILGM and Leafly announce their Home Grow Tour that will visit cities throughout the US to help educate growers on cannabis cultivation.

Avecho and Sandoz have signed an exclusive license and development agreement to commercialize CBD for use with insomnia in Australia.

Here, we bring you our top four recent news articles covering research for cannabis and ALS and autism, updates from the NCIA, and testing license applications in Alabama.

A recent study showed that retail cannabis sales may play a role in reducing drinking seen with young adults.

Village Farms International recently announced that the company will be spreading their medical cannabis distribution to New Zealand.

This webinar covered how cannabis for this neurodegenerative disease could provide better symptom relief and improve quality of life better than conventional treatments.

The Alabama Medical Cannabis Commission made the announcement in its most recent meeting, intending to advance the state medical cannabis program.

VIST Labs and Paralab have formed a strategic partnership to help expand decontamination and packaging solution options in Europe.

Adam Rosenberg’s experience across the cannabis supply chain, investment, education, and more is expected to help unify businesses toward federal legalization advocacy.

With a $3.5 billion investment plan, the company aims to become a leader in onshore API manufacturing, building DEA- and FDA-compliant facilities.

A recent press release disclosed that the FDA has granted DeFloria with a Investigational New Drug application for their AJA001 multi-cannabinoid botanical drug that may provide a new treatment for autism spectrum disorder.